Subject: Investment Opportunity: PCT-Patent Pending Closed-Loop Stroke Theranostic System
breakthrough medical devices and neurovascular innovations, I am reaching out to introduce a novel medical platform that addresses a critical bottleneck in Acute Ischemic Stroke treatment.We have developed a Closed-Loop ...
Closed-Loop Hardware and Self-Oxygenating Nanoformulation for Hypoxic Tumor Theranostics
We introduce a patented, closed-loop theranostic platform engineered to overcome severe intratumoral hypoxia in solid tumors. The system unifies an environment-responsive hybrid nanocarrier with an external, algorithmic ...
Closed-Loop Theranostic System for Targeted Artificial Cellular Respiration in Acute Cerebral Ischemia
We introduce a disruptive, non-living, highly stable neuro-theranostic platform engineered to arrest irreversible neuronal necrosis during acute ischemic stroke. The system integrates a dual-component architecture: an in...
Advanced Computational Diagnostics and Molecular Therapeutics for Retinal Disorders
Executive Summary: This proprietary biological and diagnostic asset introduces a novel, non-invasive computational approach for the management and targeting of Diabetic Retinopathy. Moving beyond conventional anti-VEGF t...
A Novel Plant-Inspired Ratio Principle, Prototype Device, and Molecular Scaffold for Diagnosis and Treatment of Diabetic Retinopathy
Executive Summary: This invention introduces a disruptive medical paradigm for the diagnosis and treatment of Diabetic Retinopathy, shifting the current standard of care from traditional VEGF inhibition to an innovative ...
Breakthrough AI mRNA Design Platform
Our innovation is a next-generation computational biotech platform designed to resolve the industry’s critical mRNA delivery and expression bottlenecks. Legally protected under International Patent Application No: PCT/IB...
delivered to your inbox.